# Angel Academe

> Angel Academe is a VC fund in London backing SaaS and Software. See 62 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: London, United Kingdom
- Total investments: 62
- Last investment: Jun 2026
- Lead investor: 26%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/angel-academe
- X (Twitter): http://twitter.com/angelacademe
- Website: http://www.angelacademe.com/

Angel Academe is a fast-growing and award-winning angel investor network. The network helps female founders and co-founders who can already demonstrate some early success with their tech startup to access a unique pool of engaged, mainly female investors. Their investors are successful entrepreneurs, operators and senior leaders and they'vecollectively invested in over 45 startups and scaleups since 2014 through 70+ funding rounds, helping them raise over £100m from angels, VCs and family offices to continue to grow their med tech, clean tech, fin tech and enterprise software businesses.

## Contacts

5 contacts available for Angel Academe. Shizune tracks 4 team members at Angel Academe. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/angel-academe?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $238k–$2.8M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| SaaS | 9 | 15% |
| Software | 8 | 13% |
| Health Care | 8 | 13% |
| Artificial Intelligence | 6 | 10% |
| Medical | 5 | 8% |

96 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 30 | 48% |
| Series A | 11 | 18% |
| Funding Round | 6 | 10% |
| Pre-Seed | 3 | 5% |
| Venture - Series Unknown | 2 | 3% |

6 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 43 | 69% |
| United States | 1 | 2% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Melissa Longley | Member | 0 | https://shizune.co/investors/profile/melissa-longley-0139 |
| Peder Bratt | Member Investor | 1 | https://shizune.co/investors/profile/peder-bratt |
| Sarah Turner | Co-founder & CEO | 1 | https://shizune.co/investors/profile/sarah-turner |
| Simon Hopkins | Co-founder & COO | 0 | https://shizune.co/investors/profile/simon-hopkins-3 |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| LabCycle | LabCycle is the world's first company to recycle hazardous plastic waste from laboratories (service) as well as the first to create 100% recycled laboratory consumables (product). Working with public and private labs, we are driving the circular economy of lab plastics to reduce the 5.5m tonnes of lab waste annually. A few highlights of ourprogress to date: • Proven impact - saving 90% of CO2 emissions & 93% energy compared to current alternatives: incineration and autoclave (LCA available upon request).• Technological validation creating the world's first 100% circular lab consumables including petri dishes, test tubes and more.• Secured commercial contracts with the NHS, several private companies and also universities. We are raising £1.5m to scale our patent pending technology to serve our growing demand after over 150+ organic expressions of interests following our feature in BBC news. The funding will establish the first automated decontamination system of our network, recycling over 350 tonnes annually, saving over 1000+ tonnes of carbon. | $238K | Seed | Jun 23, 2026 |  |
| Zonova | Zonova has developed an antimicrobial additive technology that integrates directly into the polymers used in medical device manufacture, designed to help prevent healthcare-associated infections, a problem affecting roughly 1 in 10 hospital patients worldwide (WHO, 2011). Our patented Z-ROS® chemistry is a non-leaching antimicrobial additive basedon reactive-oxygen-species generation at the polymer surface. It does not use actives, antibiotics or biocides.Z-ROS® is in development for high infection-risk device categories including vascular access devices, orthopaedic implants, urology (connectors, valves, catheters), endotracheal tubes, and pelvic health devices. The intended commercial model is licensing to medical device manufacturers, with masterbatch supply through a contracted compounder. | $2.8M | Seed | May 26, 2026 |  |
| LabCycle | LabCycle is the world's first company to recycle hazardous plastic waste from laboratories (service) as well as the first to create 100% recycled laboratory consumables (product). Working with public and private labs, we are driving the circular economy of lab plastics to reduce the 5.5m tonnes of lab waste annually. A few highlights of ourprogress to date: • Proven impact - saving 90% of CO2 emissions & 93% energy compared to current alternatives: incineration and autoclave (LCA available upon request).• Technological validation creating the world's first 100% circular lab consumables including petri dishes, test tubes and more.• Secured commercial contracts with the NHS, several private companies and also universities. We are raising £1.5m to scale our patent pending technology to serve our growing demand after over 150+ organic expressions of interests following our feature in BBC news. The funding will establish the first automated decontamination system of our network, recycling over 350 tonnes annually, saving over 1000+ tonnes of carbon. | $1.3M | Seed | Jan 19, 2026 |  |
| LabCycle | LabCycle is the world's first company to recycle hazardous plastic waste from laboratories (service) as well as the first to create 100% recycled laboratory consumables (product). Working with public and private labs, we are driving the circular economy of lab plastics to reduce the 5.5m tonnes of lab waste annually. A few highlights of ourprogress to date: • Proven impact - saving 90% of CO2 emissions & 93% energy compared to current alternatives: incineration and autoclave (LCA available upon request).• Technological validation creating the world's first 100% circular lab consumables including petri dishes, test tubes and more.• Secured commercial contracts with the NHS, several private companies and also universities. We are raising £1.5m to scale our patent pending technology to serve our growing demand after over 150+ organic expressions of interests following our feature in BBC news. The funding will establish the first automated decontamination system of our network, recycling over 350 tonnes annually, saving over 1000+ tonnes of carbon. | $1.3M | Seed | Jan 19, 2026 |  |
| Movetru | Movetru a wearable device that aims to reduce injury and enhance rehabilitation. | $1.6M | Pre-Seed | Jul 08, 2025 |  |
| Inicio AI | Inicio AI is a SaaS platform that builds the conversational AI driven tool that helps in income and expenditure assessment. | $1.7M | Seed | Apr 15, 2025 |  |
| YEO Messaging | YEO Messaging is a messaging platform that provides secure a messaging service focused on business settings. | $3.2M | Seed | Mar 06, 2025 |  |
| PreActiv | PreActiv provides personalized programs to improve treatment outcomes. The company offers prehabilitation programs that start before a surgery or cancer treatment and prepare the person andtheir body so they get the best possible results. The company was founded in 2020 and is based in London, England. | $640.8K | Pre-Seed | Jul 08, 2024 |  |
| PreActiv | PreActiv provides personalized programs to improve treatment outcomes. The company offers prehabilitation programs that start before a surgery or cancer treatment and prepare the person andtheir body so they get the best possible results. The company was founded in 2020 and is based in London, England. | $640.8K | Pre-Seed | Jul 08, 2024 |  |
| Provenance | The trusted data layer for agentic commerce. Provenance powers enriched product attributes for 300+ brands and retailers, including L’Oreal, Holland & Barrett, THG, Nestle, Unilever, LVMH, Diageo and Ocado, positioning it as a trusted infrastructure layer for AI discovery and values-driven commerce.With AI-driven commerce projected to reach$3–5 trillion by 2030, brands and retailers face a structural challenge: product claims are largely unstructured, unverifiable and lacking trust signals for AI systems. Provenance converts complex product data - certifications, sustainability, health and efficacy claims - into verified, machine-readable claims that AI systems can reliably interpret and cite, building on over a decade of domain expertise in the integrity, validation and compliance of CPG product claims. | $5M | Venture - Series Unknown | May 15, 2024 |  |

10 of 62 investments shown.

## Co-investors
- [Cambridge Capital Group](https://shizune.co/investors/profile/cambridge-capital-group) — VC Fund, 5 deals together
- [SyndicateRoom](https://shizune.co/investors/profile/syndicateroom) — VC Fund, 5 deals together
- [Amrock Ventures](https://shizune.co/investors/profile/amrock-ventures) — VC Fund, 3 deals together
- [Anglia Capital Group](https://shizune.co/investors/profile/anglia-capital-group) — VC Fund, 3 deals together
- [Cambridge Angels group](https://shizune.co/investors/profile/cambridge-angels-group) — VC Fund, 3 deals together
- [Dunamis Ventures](https://shizune.co/investors/profile/dunamis-ventures) — VC Fund, 3 deals together

## Similar investors

### Similar industry
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [AME Cloud Ventures](https://shizune.co/investors/profile/ame-cloud-ventures) — VC Fund
- [Accel](https://shizune.co/investors/profile/accel) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [SFC Capital](https://shizune.co/investors/profile/startup-funding-club) — VC Fund
- [Fuel Ventures](https://shizune.co/investors/profile/fuel-ventures-fund) — VC Fund
- [Business Growth Fund](https://shizune.co/investors/profile/business-growth-fund) — VC Fund

## Featured in investor lists
- [Internet Investors in United Kingdom](https://shizune.co/investors/internet-investors-united-kingdom)
- [Internet VC Funds in United Kingdom](https://shizune.co/investors/internet-vc-funds-united-kingdom)
- [Sustainability Investors in United Kingdom](https://shizune.co/investors/sustainability-investors-united-kingdom)
- [Sustainability VC Funds in United Kingdom](https://shizune.co/investors/sustainability-vc-funds-united-kingdom)
- [Impact Investors in United Kingdom](https://shizune.co/investors/impact-investors-united-kingdom)
- [Impact VC Funds in United Kingdom](https://shizune.co/investors/impact-vc-funds-united-kingdom)

## FAQ

### What does Angel Academe invest in?

Angel Academe invests primarily in SaaS, Software and Health Care startups, most often at Seed and Series A stage. Most of the 62 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Angel Academe's check size?

Angel Academe typically joins rounds of $238k–$2.8M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Angel Academe participates in.

### How do I contact Angel Academe?

Public channels for Angel Academe include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Angel Academe?

The team at Angel Academe includes Melissa Longley (Member), Peder Bratt (Member Investor) and Sarah Turner (Co-founder & CEO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co